Drugs / abobotulinum toxin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03887377 | Jun 2019 → Dec 2024 | breast disorder, reactive cutaneous fibrous lesion | Henry Ford Health System | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | abobotulinum toxin | “Injection abobotulinum toxin at time of surgery, single injection time with 30 gauge needle superficially, dosage determined by length of scar 5-15U per cm” NCT03887377 ↗ |
| Route | Other | “injected into the surgical incision at the time of surgery” NCT03887377 ↗ |